The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 328:1843-1844 June 24, 1993 Number 25
NextNext

The Changing Spectrum of Group B Streptococcal Disease

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Early in this century, Rebecca Lancefield discovered that {beta}-hemolytic streptococci could be classified into serogroups according to the immunoprecipitation of bacterial extracts with specific antiserum. With the development of the Lancefield system, other {beta}-hemolytic streptococci were distinguished from group A streptococcus, or Streptococcus pyogenes, the agent of streptococcal pharyngitis, impetigo, and the poststreptococcal syndromes of acute rheumatic fever and glomerulonephritis. The recognition of group B streptococci, or S. agalactiae, as an important cause of human disease has grown since 1938, when Fry reported three cases of puerperal sepsis due to these organisms1. In the mid-1970s, hospital-based surveys suggested that . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.